The High-Stakes Gamble: Why Late-Stage Drug Development Is a Ticking Time Bomb For investors, the biopharmaceutical pipeline represents both a […]

For seasoned professionals in intellectual property (IP), research and development (R&D), and business development, the simple question, “What is the

The story of generic drugs is often told in simple terms: they are the affordable alternatives that save patients and

In pharmaceutical and biotechnology innovation patent litigation is not merely a legal hurdle; it is a multi-million-dollar crucible where market

Welcome. If you’re a professional in the pharmaceutical and biotech space, you understand that the conversation about generic drugs goes

Introduction The branded pharmaceutical industry, long a bastion of high-margin innovation, stands at a precipice. It is caught in the

Introduction: The 20-Year Illusion and the Race for Effective Patent Life In pharmaceutical innovation the 20-year patent term is both

The market value of a pharmaceutical company is the discounted sum of its future cash flows, and those cash flows

Pharmaceteutical stock valuation is an exercise in probabilistic accounting. Traditional financial metrics fail because they are retrospective. A price-to-earnings (P/E)